A detailed history of Webster Bank, N. A. transactions in Novartis Ag stock. As of the latest transaction made, Webster Bank, N. A. holds 375 shares of NVS stock, worth $36,918. This represents 0.0% of its overall portfolio holdings.

Number of Shares
375
Previous 375 -0.0%
Holding current value
$36,918
Previous $39,000 10.26%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 10, 2023

SELL
$94.73 - $105.13 $61,574 - $68,334
-650 Reduced 63.41%
375 $38,000
Q4 2022

Jan 18, 2023

SELL
$75.55 - $92.52 $11,332 - $13,878
-150 Reduced 12.77%
1,025 $93,000
Q4 2021

Jan 12, 2022

SELL
$79.7 - $88.13 $5,977 - $6,609
-75 Reduced 6.0%
1,175 $103,000
Q3 2021

Oct 12, 2021

SELL
$81.78 - $95.14 $32,712 - $38,056
-400 Reduced 24.24%
1,250 $102,000
Q2 2021

Jul 20, 2021

SELL
$85.24 - $94.15 $10,655 - $11,768
-125 Reduced 7.04%
1,650 $151,000
Q1 2021

May 07, 2021

SELL
$83.5 - $98.47 $14,529 - $17,133
-174 Reduced 8.93%
1,775 $151,000
Q4 2020

Jan 07, 2021

SELL
$78.07 - $94.43 $11,007 - $13,314
-141 Reduced 6.75%
1,949 $184,000
Q3 2020

Oct 22, 2020

SELL
$82.14 - $91.0 $9,035 - $10,010
-110 Reduced 5.0%
2,090 $182,000
Q1 2020

Apr 21, 2020

SELL
$70.67 - $99.01 $17,667 - $24,752
-250 Reduced 10.2%
2,200 $181,000
Q4 2019

Jan 14, 2020

BUY
$84.35 - $95.37 $4,217 - $4,768
50 Added 2.08%
2,450 $232,000
Q1 2019

Apr 10, 2019

SELL
$75.32 - $86.15 $13,180 - $15,076
-175 Reduced 6.8%
2,400 $231,000
Q3 2018

Oct 12, 2018

SELL
$66.94 - $77.43 $31,127 - $36,004
-465 Reduced 15.3%
2,575 $222,000
Q2 2018

Jul 12, 2018

SELL
$64.91 - $73.36 $37,323 - $42,182
-575 Reduced 15.91%
3,040 $229,000
Q1 2018

Apr 19, 2018

SELL
$70.39 - $84.15 $63,351 - $75,735
-900 Reduced 19.93%
3,615 $293,000
Q4 2017

Jan 23, 2018

SELL
$72.33 - $77.64 $23,507 - $25,233
-325 Reduced 6.71%
4,515 $379,000
Q3 2017

Oct 12, 2017

BUY
$74.14 - $77.27 $358,837 - $373,986
4,840
4,840 $416,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Webster Bank, N. A. Portfolio

Follow Webster Bank, N. A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Webster Bank, N. A., based on Form 13F filings with the SEC.

News

Stay updated on Webster Bank, N. A. with notifications on news.